ESTRO 2023 - Abstract Book

S733

Monday 15 May 2023

ESTRO 2023

Conclusion We developed dosimetric indicators for ART planning QA that can identify the low quality adaptive plans for stereotactic pancreatic ART. These metrics can be used to identify deviations or actual errors during the online adaptive process, which could be useful as an ART clinical trial QA tool, reference tool for new users, and improve overall ART quality at an institution.

Poster Discussion: GI

PD-0885 Patient-reported outcomes after rectal cancer treatment on a 1.5T MR-Linac within the MOMENTUM study